Skip to main content
SpringerLink
Log in

Abiraterone/docetaxel

Lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Satapathy S, et al. Response to Concomitant Enzalutamide and 177Lu-PSMA-617 Radioligand Therapy in ATM -Mutated Metastatic Castration Resistant Prostate Cancer. Clinical Nuclear Medicine 46: 582-583, No. 7, 2021. Available from: URL: http://doi.org/10.1097/RLU.0000000000003541

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abiraterone/docetaxel. Reactions Weekly 1900, 14 (2022). https://doi.org/10.1007/s40278-022-12366-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-12366-8

Search

Navigation